Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2
Release Date:
Moderator: Johann Sellner (Mistelbach, Austria)Guest: Tamuna Akhvlediani (Tbilisi, Georgia)In this podcast episode, Prof. Johann Sellner interviews Prof. Tamuna Akhvlediani about the neurological aspects of new antiviral drugs for SARS-CoV-2. They discuss drugs like monoclonal antibodies, paxlovid, and remdesivir, emphasizing their mechanisms and potential applications beyond COVID-19. Prof. Akhvlediani details neurological side effects observed in trials and significant drug interactions, especially in chronic neurological patients. The episode closes with insights into managing these interactions in clinical practice.
Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2